Shawna Weisler, MD
Endocrinology · Burbank, CANPI 1962501858
Payments from drug & device makers
Across 695 payments — averaging $64.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$24K
- Dexcom, Inc.$9K
- Novo Nordisk$3K
- Mannkind Corporation$1K
- Lilly USA, LLC$838
- Abbott$809
- plus $6K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 75 | $23,890 |
| Dexcom, Inc. | 59 | $8,813 |
| Novo Nordisk | 150 | $3,135 |
| Mannkind Corporation | 55 | $1,381 |
| Lilly USA, LLC | 44 | $838 |
| Abbott | 38 | $809 |
| Xeris Pharmaceuticals, Inc. | 31 | $730 |
| Sanofi-aventis U.S. LLC | 35 | $727 |
| AbbVie | 22 | $567 |
| Sequel Med Tech, LLC | 15 | $459 |
| Boehringer Ingelheim | 18 | $423 |
| Amgen | 14 | $359 |
| Companion Medical, Inc. | 11 | $326 |
| Antares Pharma, Inc. | 11 | $241 |
| IBSA Pharma Inc. | 20 | $237 |
| Merck | 11 | $204 |
| Radius Health, Inc. | 6 | $157 |
| Zealand Pharma US, Inc. | 10 | $140 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $138 |
| Tandem Diabetes Care, Inc. | 9 | $134 |
| Amarin Pharma, Inc. | 5 | $131 |
| Valeritas, Inc. | 11 | $131 |
| Bayer | 1 | $130 |
| Medtronic(2 entities) | 5 | $97 |
| Eisai Inc. | 4 | $84 |
| Insulet Corporation | 4 | $79 |
| Currax Pharmaceuticals LLC | 4 | $66 |
| Corcept Therapeutics | 3 | $64 |
| Halozyme Inc | 3 | $60 |
| Kowa Pharmaceuticals America, Inc. | 3 | $55 |
| Alfasigma USA, Inc. | 3 | $54 |
| Vistapharm, Inc. | 3 | $51 |
| Shire North American Group Inc | 2 | $48 |
| Biogen | 1 | $42 |
| BD | 2 | $40 |
| Embecta Corp. | 1 | $30 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Cequr Corporation | 1 | $26 |
| Vivus LLC | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $21 |
| Ascensia Diabetes Care US Inc. | 1 | $18 |
How this compares
$44,990 in reported general payments places this provider in the 90th percentile of 58 endocrinology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology in Burbank
- Minh MachBurbank$650K
- Joseph HawkinsFresno$477K
- Michael BushBeverly Hills$380K
- Ashiq PatelLancaster$32K
- Paul AzerBeverly Hills$25K
- Michael TranAnaheim$16K
- Samuel MayedaOrange$11K
- Daniel KaplanSan Leandro$8K
- Amy van BuiMission Viejo$8K
- Sandeep ChaudharyLaguna Hills$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.